UniProtKB/Swiss-Prot P50542 : Variant p.Asn526Lys
Peroxisomal targeting signal 1 receptor
Gene: PEX5
Feedback ?
Variant information
Variant position:
526
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:
LP/P [Disclaimer : Variants classification is intended for research purposes only, not for clinical and diagnostic use . The label disease variant is assigned according to literature reports on probable disease-association that can be based on theoretical reasons. This label must not be considered as a definitive proof for the pathogenic role of a variant. ]
The variants are classified into three categories: LP/P, LB/B and US.LP/P: likely pathogenic or pathogenic. LB/B: likely benign or benign. US: uncertain significance
Residue change:
From Asparagine (N) to Lysine (K) at position 526 (N526K, p.Asn526Lys).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:
Change from medium size and polar (N) to large size and basic (K)
The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:
0
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another: Lowest score: -4 (low probability of substitution).Highest score: 11 (high probability of substitution). More information can be found on the following page
Variant description:
In PBD2B; neonatal adrenoleukodystrophy; strongly affects peroxisomal protein import containing a C-terminal PTS1-type targeting signal without affecting import of proteins with a PTS2 targeting signal.
Any additional useful information about the variant.
Other resources:
Links to websites of interest for the variant.
Sequence information
Variant position:
526
The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:
639
The length of the canonical sequence.
Location on the sequence:
KAVDCFTAALSVRPNDYLLW
N KLGATLANGNQSEEAVAAYR
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:
The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human KAVDCFTAALSVRPNDYLLWN KLGATLANGNQSEEAVAAYR
Mouse KAVDCFTAALSVRPNDYLMWN KLGATLANGNQSEEAVAAYR
Rat KAVDCFTAALSVRPNDYLLWN KLGATLANGNQSEEAVAAYR
Bovine KAVDCFTAALSVRPDDYLLWN KLGATLANGNQSEEAVAAYR
Chicken KAVDCFSAALSVRPNDHLLWN KLGATLANGNRSEEAVAAYR
Xenopus laevis KAVDCFTAALGQRPDDYLLWN KLGATLANGNDSEAAVEAYR
Slime mold KAVDCFKAALQNSPTDYQLWN KLGATLANSNRSQEALGAYF
Baker's yeast KTIDCFESALRVNPNDELMWN RLGASLANSNRSEEAIQAYH
Fission yeast RSADCFRQALQDEPSNEILWN KLGAALTNAEKNTEAVSSYN
Sequence annotation in neighborhood:
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
1 – 639
Peroxisomal targeting signal 1 receptor
Repeat
522 – 555
TPR 6
Cross
527 – 527
Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)
Mutagenesis
527 – 527
K -> A. Does not affect monoubiquitination by TRIM37.
Mutagenesis
527 – 527
K -> R. Does not affect PEX5 recycling.
Helix
522 – 534
Literature citations
Mutations in the PTS1 receptor gene, PXR1, define complementation group 2 of the peroxisome biogenesis disorders.
Dodt G.; Braverman N.; Wong C.; Moser A.; Moser H.W.; Watkins P.; Valle D.; Gould S.J.;
Nat. Genet. 9:115-125(1995)
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2); INVOLVEMENT IN PBD2A; VARIANTS PBD2B 427-ARG--GLN-639 DEL AND LYS-526; FUNCTION; SUBCELLULAR LOCATION; TISSUE SPECIFICITY;
An isoform of pex5p, the human PTS1 receptor, is required for the import of PTS2 proteins into peroxisomes.
Braverman N.; Dodt G.; Gould S.J.; Valle D.;
Hum. Mol. Genet. 7:1195-1205(1998)
Cited for: FUNCTION (ISOFORM 1); CHARACTERIZATION OF VARIANTS PBD2B 427-ARG--GLN-639 DEL AND LYS-526;
Functional heterogeneity of C-terminal peroxisome targeting signal 1 in PEX5-defective patients.
Shimozawa N.; Zhang Z.; Suzuki Y.; Imamura A.; Tsukamoto T.; Osumi T.; Fujiki Y.; Orii T.; Barth P.G.; Wanders R.J.; Kondo N.;
Biochem. Biophys. Res. Commun. 262:504-508(1999)
Cited for: VARIANTS PBD2B LYS-526 AND TRP-600; CHARACTERIZATION OF VARIANTS PBD2B LYS-526 AND TRP-600;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.